Cargando…
Rapid clinical improvement of atopic dermatitis in an Omalizumab treated patient
BACKGROUND: Atopic dermatitis is a chronic inflammatory skin disorder, whose symptoms and severity grossly depend on individual trigger factors. The majority of patients are satisfactorily treated with emollients together with topical and systemic therapies. However, treatment failure or long-term s...
Autores principales: | Bormioli, Susanna, Matucci, Andrea, Dies, Laura, Nencini, Francesca, Grosso, Francesca, Maggi, Enrico, Vultaggio, Alessandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413441/ https://www.ncbi.nlm.nih.gov/pubmed/30911288 http://dx.doi.org/10.1186/s12948-019-0109-z |
Ejemplares similares
-
T Cell Response to Infliximab in Exposed Patients: A Longitudinal Analysis
por: Pratesi, Sara, et al.
Publicado: (2019) -
Drug-specific Treg cells are induced during desensitization procedure for rituximab and tocilizumab in patients with anaphylaxis
por: Vultaggio, Alessandra, et al.
Publicado: (2021) -
Low-Dose Mepolizumab Effectiveness in Patients Suffering From Eosinophilic Granulomatosis With Polyangiitis
por: Vultaggio, Alessandra, et al.
Publicado: (2020) -
Mechanisms of Drug Desensitization: Not Only Mast Cells
por: Vultaggio, Alessandra, et al.
Publicado: (2020) -
Asthma and Chronic Rhinosinusitis: How Similar Are They in Pathogenesis and Treatment Responses?
por: Matucci, Andrea, et al.
Publicado: (2021)